210 MAIN STREET WEST, BAUDETTE, MN
Appoints Henry Gosebruch to Board of Directors
Financial Results, Reg. FD
Stockholders Approve Amended 2022 Stock Incentive Plan
Investor Presentation
Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance
Annual Report to Security Holders
ANI Pharmaceuticals Dismisses EisnerAmper as Independent Accountant
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Confidential Treatment Order
Submission Upload